Effects of Unilateral Stimulation in Parkinson's Disease: A Randomized Double-Blind Crossover Trial

被引:4
|
作者
Zeng, Zhitong [1 ]
Wang, Linbin [1 ,2 ]
Shi, Weikun [3 ]
Xu, Lu [1 ]
Lin, Zhengyu [1 ]
Xu, Xinmeng [1 ]
Huang, Peng [1 ]
Pan, Yixin [1 ]
Chen, Zhonglue [3 ]
Ling, Yun [3 ]
Ren, Kang [3 ]
Zhang, Chencheng [1 ]
Sun, Bomin [1 ]
Li, Dianyou [1 ]
机构
[1] Shanghai Jiao Tong Univ, Ruijin Hosp, Ctr Funct Neurosurg, Dept Neurosurg,Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Inst Sci & Technol Brain, Inspired Intelligence, Shanghai, Peoples R China
[3] Gyenno Sci Co LTD, Shenzhen, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
deep brain stimulation (DBS); Parkinson's disease; globus pallidus interna; subthalamic nucleus; personalized treatment; DEEP-BRAIN-STIMULATION; GLOBUS-PALLIDUS INTERNA; SUBTHALAMIC NUCLEUS; MEDICAL THERAPY; SYMPTOMS; SURGERY;
D O I
10.3389/fneur.2021.812455
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionPrevious studies have shown that subthalamic nucleus (STN) and unilateral globus pallidus interna (GPi) are similarly effective in the deep brain stimulation (DBS) treatment of motor symptoms. However, the counterintuitively more common clinical application of STN DBS makes us hypothesize that STN is superior to GPi in the treatment of motor symptoms. MethodsIn this prospective, double-blind, randomized crossover study, idiopathic PD patients treated with combined unilateral STN and contralateral GPi DBS (STN in one brain hemisphere and GPi in the other) for 2 to 3 years were enrolled. The MDS UPDRS-III total score and subscale scores for axial and bilateral limb symptoms were assessed preoperatively and at 2- to 3-year follow-up in four randomized, double-blinded conditions: (1) Med-STN+GPi-, (2) Med-STN-GPi+, (3) Med+STN+GPi-, and (4) Med+STN-GPi+. ResultsEight patients had completed 30 trials of assessment. Compared with the preoperative Med- state, in the Med-STN+GPi- condition, the cardinal symptoms in both sides of the body were all improved. In the Med-STN-GPi+ condition, symptoms of the GPi-stim limb were improved, while only tremor was improved on the ipsilateral side, although all axial symptoms showed aggravation. Compared with the preoperative Med+ state, in the Med+STN+GPi- state, cardinal symptoms were improved on both sides, except that tremor was worsened on the STN-stim side. In the Med+STN-GPi+ state, the overall motor symptoms were aggravated compared with the preoperative Med+ state. Most axial symptoms worsened at acute unilateral STN or GPi DBS onset, compared to both preoperative Med- and Med+ states. No side effects associated with this study were seen. ConclusionsImprovement in motor symptoms was greater in all sub-scores favoring STN. The effects of STN+ were seen on both sides of the body, while GPi+ mainly acted on the contralateral side.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Unilateral Subthalamic Versus Unilateral Pallidal Stimulation in Parkinson's Disease: A Randomized Double-Blind Crossover Study
    Zhang, C. C.
    Zeng, Z. T.
    Wang, L. B.
    Shi, W. K.
    Lin, Z. Y.
    Sun, B. M.
    Li, D. Y.
    MOVEMENT DISORDERS, 2021, 36 : S200 - S200
  • [2] Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
    Schnitzler, Alfons
    Mir, Pablo
    Brodsky, Matthew A.
    Verhagen, Leonard
    Groppa, Sergiu
    Alvarez, Ramiro
    Evans, Andrew
    Blazquez, Marta
    Nagel, Sean
    Pilitsis, Julie G.
    Poetter-Nerger, Monika
    Tse, Winona
    Almeida, Leonardo
    Tomycz, Nestor
    Jimenez-Shahed, Joohi
    Libionka, Witold
    Carrillo, Fatima
    Hartmann, Christian J.
    Groiss, Stefan Jun
    Glaser, Martin
    Defresne, Florence
    Karst, Edward
    Cheeran, Binith
    Vesper, Jan
    NEUROMODULATION, 2021,
  • [3] Short Pulse Width in Subthalamic Stimulation in Parkinson's Disease: a Randomized, Double-Blind Study
    Bouthour, Walid
    Wegrzyk, Jennifer
    Momjian, Shahan
    Peron, Julie
    Fleury, Vanessa
    Chaoui, Emilie Tomkova
    Horvath, Judit
    Boex, Colette
    Luscher, Christian
    Burkhard, Pierre R.
    Krack, Paul
    Zacharia, Andre
    MOVEMENT DISORDERS, 2018, 33 (01) : 169 - 173
  • [4] A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease
    Iwaki, Hirotaka
    Ando, Rina
    Tada, Satoshi
    Nishikawa, Noriko
    Tsujii, Tomoaki
    Yamanishi, Yuki
    Miyaue, Noriyuki
    Yabe, Hayato
    Nagai, Masahiro
    Nomoto, Masahiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2020, 414
  • [5] Reprogramming of updated neurostimulators in chronically implanted patients with Parkinson's disease: A double-blind randomized controlled trial
    Boogers, Alexandra
    Justich, Maria Belen
    Montiel, Marcela
    Alhashyan, Ibrahim
    Naghdlou, Sara
    Sumarac, Srdjan
    Milosevic, Luka
    Lozano, Andres M.
    Kalia, Suneil K.
    Munhoz, Renato P.
    Fasano, Alfonso
    BRAIN STIMULATION, 2025, 18 (01) : 138 - 140
  • [6] Directional versus ring-mode deep brain stimulation for Parkinson's disease: protocol of a multi-centre double-blind randomised crossover trial
    Brinke, Timo R. ten
    Jergas, Hannah
    Sisodia, Vibuthi
    Barbe, Michael T.
    Odekerken, Vincent J. J.
    Verbaan, Dagmar
    Dijk, Joke M.
    Bot, Maarten
    Beudel, Martijn
    van den Munckhof, Pepijn
    Schuurman, P. Rick
    de Bie, Rob M. A.
    BMC NEUROLOGY, 2023, 23 (01)
  • [7] Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study
    Germano, IM
    Gracies, JM
    Weisz, DJ
    Tse, W
    Koller, WC
    Olanow, CW
    JOURNAL OF NEUROSURGERY, 2004, 101 (01) : 36 - 42
  • [8] Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial
    Chagas, Marcos Hortes N.
    Zuardi, Antonio W.
    Tumas, Vitor
    Pena-Pereira, Marcio Alexandre
    Sobreira, Emmanuelle T.
    Bergamaschi, Mateus M.
    dos Santos, Antonio Carlos
    Teixeira, Antonio Lucio
    Hallak, Jaime E. C.
    Crippa, Jose Alexandre S.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (11) : 1088 - 1092
  • [9] Effect of memantine (NMDA antagonist) on Parkinson's disease: A double-blind crossover randomized study
    Merello, M
    Nouzeilles, MI
    Cammarota, A
    Leiguarda, R
    CLINICAL NEUROPHARMACOLOGY, 1999, 22 (05) : 273 - 276
  • [10] Modafinil for the treatment of daytime sleepiness in Parkinson's disease:: A double-blind, randomized, crossover, placebo-controlled polygraphic trial
    Högl, B
    Saletu, M
    Brandauer, E
    Glatzl, S
    Frauscher, B
    Seppi, K
    Ulmer, H
    Wenning, G
    Poewe, W
    SLEEP, 2002, 25 (08): : 905 - 909